Santa Cruz Biotechnology offers a broad range of TRIM49 monoclonal antibodies for investigating TRIM49's role in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TRIM49, a member of the tripartite motif (TRIM) family, plays a key role in regulating immune responses and modulating viral infections. TRIM49's involvement in the ubiquitin-proteasome system is essential for maintaining cellular homeostasis and influencing various signaling pathways. Research has shown that TRIM49 expression levels can vary significantly across different tissue types and cellular conditions. Understanding TRIM49's molecular mechanisms and interactions can reveal new therapeutic strategies for immune-related disorders. Recent studies have highlighted TRIM49's potential involvement in antiviral defense mechanisms. Ongoing research continues to uncover new functions and regulatory pathways associated with TRIM49. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TRIM49's biological significance and therapeutic potential.